SCHEMBL21875164

SCHEMBL21875164

COc1ccc(S(=O)(=O)n2ccc(C(=O)NCc3cnc(C)cn3)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 4/20 0.60
▸ ALDH1A1 P00352 5/20 0.47
▸ CYP1A2 P05177 3/20 0.47
▸ CYP3A4 P08684 3/20 0.47
▸ CYP2C19 P33261 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MAPT P10636 4/20 0.47
▸ NAMPT P43490 3/20 0.45
▸ TP53 P04637 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ TSHR P16473 2/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21875069 0.90 NAMPT (0.48) KLKB1NAMPT
SCHEMBL21875152 0.88 KLKB1 (0.60) KLKB1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL21875093 0.88 NAMPT (0.46) KLKB1ALDH1A1MAPTNAMPT
SCHEMBL21875108 0.88 PKM (0.52) KLKB1NAMPT
SCHEMBL21875180 0.87 KLKB1 (0.50) KLKB1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL21875082 0.86 KLKB1 (0.58) KLKB1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL21875107 0.86 KLKB1 (0.58) KLKB1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL21875175 0.86 KLKB1 (0.49) KLKB1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL21875127 0.85 GRM4 (0.47) KLKB1MAPTNAMPT
SCHEMBL21875078 0.85 NAMPT (0.44) KLKB1ALDH1A1MAPTNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3873891-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS KV3 POTASSIUM CHANNEL ACTIVATORS H. Lundbeck A/S (DK) 2021-09-08 — — EP claimed
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN claimed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US claimed
EP-3873891-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS KV3 POTASSIUM CHANNEL ACTIVATORS H. Lundbeck A/S (DK) 2021-09-08 — — EP disclosed
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS KCNA3, KCNN3, KCNK3 KLKB1 784/4885ALDH1A1 4451/4885CYP1A2 3366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback